Oncofertility in the era of targeted therapy: Tyrosine kinase inhibitors, female reproductive toxicity, and pregnancy outcomes.
- DOI
- 10.1016/j.reprotox.2026.109237
- Published
- 2026 Aug
- Container
- Reproductive toxicology (Elmsford, N.Y.)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.reprotox.2026.109237,
title = {Oncofertility in the era of targeted therapy: Tyrosine kinase inhibitors, female reproductive toxicity, and pregnancy outcomes.},
author = {Albarakati RG and Hamza E and El-Nablaway M},
year = {2026},
journal = {Reproductive toxicology (Elmsford, N.Y.)},
doi = {10.1016/j.reprotox.2026.109237},
url = {https://doi.org/10.1016/j.reprotox.2026.109237}
}RIS
TY - JOUR TI - Oncofertility in the era of targeted therapy: Tyrosine kinase inhibitors, female reproductive toxicity, and pregnancy outcomes. AU - Albarakati RG AU - Hamza E AU - El-Nablaway M PY - 2026 JO - Reproductive toxicology (Elmsford, N.Y.) DO - 10.1016/j.reprotox.2026.109237 UR - https://doi.org/10.1016/j.reprotox.2026.109237 ER -
APA
RG, A., E, H., & M, E. (2026). Oncofertility in the era of targeted therapy: Tyrosine kinase inhibitors, female reproductive toxicity, and pregnancy outcomes.. Reproductive toxicology (Elmsford, N.Y.). https://doi.org/10.1016/j.reprotox.2026.109237
Source records
- pubmed · retrieved 2026-09-26T08:53:13.605Z